Search Results 131-140 of 17654 for ulcerative colitis

  1. An Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis - Mayo Clinic

    The purpose of the trial is to determine the safety and efficacy of RPC1063 in patients diagnosed with moderate to severe ulcerative colitis. Participation ...

  2. Mayo Clinic Minute: What is inflammatory bowel disease? Video Audio People often associate inflammatory bowel disease with t

    There are two main types of IBD: Crohn's disease and ulcerative colitis. Victor Chedid, M.D.. Gastroenterology. Mayo Clinic. "Ulcerative colitis only impacts ...

  3. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Participation eligibility · Presence of Crohn's disease, indeterminate colitis, ischemic colitis, fulminant colitis, ulcerative proctitis, or toxic mega-colon ...

  4. Crohn's disease - Doctors and departments - Mayo Clinic

    Colonoscopy, Flexible sigmoidoscopy, Upper endoscopy, Ulcerative colitis, Crohn's disease, Microscopic colitis, Immune-...related adverse event. Show more ...

  5. Low-fiber diet do's and don'ts - Mayo Clinic

    This may be due to a tumor or an inflammatory disease, such as Crohn's disease and ulcerative colitis. You have had bowel surgery. You are having treatment ...

  6. A Study to Evaluate the Safety and Effectiveness of Ustekinumab Induction and Maintenance Therapy in Participants with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.

  7. Ulcerative colitis — a disease that causes ulcers and swelling called inflammation in the lining of the large intestine. Causes shown here are commonly ...

  8. A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302) - Mayo Clinic

    ... Ulcerative Colitis (FIGARO UC 302). Print details. Share; Facebook · Twitter ... ulcerative colitis (UC). Participation eligibility. Participant eligibility ...

  9. A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis · Overview.

  10. Convergence Science Program Archives - Mayo Clinic News Network

    ... (IBD) is an umbrella term used to describe disorders that involve chronic inflammation of the digestive tract. There are two common types: ulcerative colitis ...